Home/Filings/4/0001638599-21-000217
4//SEC Filing

REFSLAND EARL R 4

Accession 0001638599-21-000217

CIK 0000874710other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 12:21 PM ET

Size

4.6 KB

Accession

0001638599-21-000217

Insider Transaction Report

Form 4
Period: 2021-02-22
REFSLAND EARL R
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2021-02-22$6.04/sh6,543$39,520179,887 total
Footnotes (1)
  • [F1]Number of shares reflects reverse stock split effected on December 5, 2016.

Issuer

ALLIED HEALTHCARE PRODUCTS INC

CIK 0000874710

Entity typeother

Related Parties

1
  • filerCIK 0001160118

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 12:21 PM ET
Size
4.6 KB